Publications

    1. Guo W, Liu F, Cheng J, Su Q, Zhang Z, Li H, Zhu F, Fan X, Zhao J. Disrupted asymmetry of inter- and intra-hemispheric functional connectivity in patients with drug-naive, first-episode schizophrenia and their unaffected siblings. EBioMedicine, 2018; pii: S2352-3964(18)30370-0. PMID: 30241918.
    2. Yuan X, Zhang P, Wang, Y, Liu Y, Li X, Kumar B, Hei G, Lv L, Huang X, Fan X, Song X. Changes in metabolism and microbiota after 24-week risperidone treatment in drug naïve, normal weight patients with first episode schizophrenia. Schizophrenia Research, in press. PMID: 29859859.
    3. Liu F, Zhang B, Xie L, Ruan Y, Xu X, Zeng Y, Messina L, Zhang J, Fan X. Changes in plasma levels of nitric oxide metabolites and negative symptoms after 16-week minocycline treatment in patients with schizophrenia. Schizophrenia Research, in press. PMID: 29526457.
    4. Goff DC, Zeng B, Ardekani BA, Diminich ED, Tang Y, Fan X, Galatzer-Levy I, Li C, Troxel AB, Wang J. Association of hippocampal atrophy with duration of untreated psychosis and molecular biomarkers during initial antipsychotic treatment of first episode psychosis. JAMA Psychiatry, 2018; 75, 370-378. PMID: 29466532.
    5. Luo Y, Liu F, Natarajan R, Shukair N, Copeland P, Fan X. Salsalate as an adjunctive treatment for psychopathology and cognition in patients with schizophrenia: a proof of concept study. International Clinical Psychopharmacology, 2018; 33, 88-91. PMID: 29084087.
    6. Liu F, Xie L, Zhang B, Ruan Y, Zeng Y, Xu X, Zhao J, Fan X. No effect of adjunctive minocycline treatment on body metabolism in patients with schizophrenia. Journal of Clinical Psychopharmacology, 2018; 38, 125-128. PMID: 29424804.
    7. Lyu X, Du J, Zhan, G, Wu Y, Su H, Zhu Y, Jarskog F, Zhao M, Fan X. Naltrexone and bupropion combination treatment for smoking cessation and weight loss in patients with schizophrenia. Frontiers in Pharmacology, 2018; 9:181. doi: 10.3389/fphar. PMID: 29563871.
    8. Ruan X, Zhong N, Yang Z, Fan X, Zhuang W, Du J, Jiang H, Zhao M. Gray matter volume showed dynamic alterations in methamphetamine users at 6 and 12 months abstinence: a longitudinal voxel-based morphometry study. Progress in Neuropsychopharmacology and Biological Psychiatry, 2018; 81, 350-355. PMID: 28887180.
    9. Wang S, Zhang Y, Lv L, Wu, R, Fan X, Zhao J, Guo W. Abnormal regional homogeneity as a potential imaging biomarker for adolescent-onset schizophrenia: a resting-state fMRI study and support vector machine analysis. Schizophrenia Research, 2018; 192, 179-184. PMID: 28587813.
    10. Fan X, Song X, Jarskog, LF, Natarajan R, Shukair N, Freudenreich O, Henderson DC, Goff DC. The effect of adjunctive telmisartan treatment on psychopathology and cognition in patients with schizophrenia. Acta Psychiatrica Scandinavica, 2017; 136, 465-472. PMID: 28851055.
    11. Zhao Z, Huang T, Tang C, Ni K, Pan X, Yan C, Fan X, Xu D, Luo Y. Altered Resting-State Intra- and Inter- Network Functional Connectivity in Patients with Persistent Somatoform Pain Disorder. PLoS One, 2017; 12(4):e0176494. doi: 10.1371/journal.pone.0176494. PMID:28453543.
    12. Wang Y, Tang W, Fan X, Zhang J, Geng D, Jiang K, Zhu D, Song Z, Xiao Z, Liu D. Resting-state functional connectivity changes within the default mode network and the salience antipsychotic treatment in early-phase schizophrenia. Neuropsychiatric Disease and Treatment, 2017. 13:397-406. doi:10.2147/NDT. S123598. PMID: 28223812.
    13. Pang L, Kennedy D, Wei Q, Lv L, Gao J, Li H, Quan M, Li X, Yang Y, Fan X, Song X. Decreased functional connectivity of insular cortex in drug naïve first episode schizophrenia: in relation to symptom severity. PLoS One, 2017; 12(1):e0167242. doi: 10.1371/journal.pone.0167242. PMID: 28107346.
    14. Liu D, Ji C, Zhuo K, Song Z, Wang Y, Mei L, Zhu D, Xiang Q, Chen T, Yang Z, Zhu G, Wang Y, Cheung EF, Xiang YT, Fan X, Chan RC, Xu Y, Jiang K. Impaired cue identification and intention retrieval underlie prospective memory deficits in patients with first-episode schizophrenia. Australia and New Zealand Journal of Psychiatry, 2017; 51, 270-277. PMID: 27004487.
    15. Luo Y, Yan C, Huang T, Fan M, Liu L, Zhao Z, Ni K, Jiang H, Huang X, Lu Z, Wu W, Zhang M, Fan X. Altered Neural Correlates of Emotion Associated Pain Processing in Persistent Somatoform Pain Disorder: An fMRI Study. Pain Practice, 2016. doi: 10.1111/papr.12358. PMID: 27641732.
    16. Zou T, Wu C, Fan X. The clinical value, principle, and basic practical technique of mindfulness intervention. Shanghai Arch of Psychiatry, 2016. 28, 121-130. PMID: 28638181.
    17. Zeng B, Ardekani BA, Tang Y, Zhang T, Zhao S, Cui H, Fan X, Zhuo K, Li C, Xu Y, Goff DC, Wang J. Abnormal white matter microstructure in drug-naive first episode schizophrenia patients before and after eight weeks of antipsychotic treatment.Schizophrenia Research,2016. 172(1-3):1-8. PMID: 26852402.
    18. Zhang Y, Zheng J, Fan X, Guo X, Guo W, Yang G, Chen H, Zhao J, Lv L.Dysfunctional resting-state connectivities of brain regions with structural deficits in drug-naive first-episode schizophrenia adolescents.Schizophrenia Research, 2015; 168,353-359. PMID: 26281967
    19. Du J, Quan M, Zhuang W, Zhong N, Jiang H, Kennedy D, Harrington A, Ziedonis D, Fan X, Zhao M. Hippocampal volume reduction in female but not male recent abstinent methamphetamine users. Behavioral Brain Research, 2015; 289, 78-83. PMID: 25920682.
    20. Tang Y, Li Y, Zhuo K, Wang Y, Liao L, Song Z, Li H, Fan X, Goff DC, Wang J, Xu Y, Liu D. Neural correlates of the preserved inhibition of return in schizophrenia. PLoS, 2015; 10:e0119521. doi: 10.1371/journal.pone.0119521. PMID: 25875486.
    21. Song X, Quan M, Lv L, Li X, Pang L, Kennedy D, Hodge S, Harrington A, Ziedonis D, Fan X.Decreased cortical thickness in drug naïve first episode schizophrenia: in relation to serum levels of BDNF.  Journal of Psychiatric Research, 2015; 60, 22-28. PMID: 25282282.
    22. Song X, Pang L, Feng Y, Fan X, Li X, Zhang W, Gao J, Zhang J, Nemani K, Zhang H, Lv L.  Fat-mass and obesity-associated gene polymorphisms and weight gain after risperidone treatment in first episode schizophrenia.  Behavior and Brain Function, 2014; 10, 35. doi: 10.1186/1744-9081-10-35. PMID: 25278160.
    23. Song X, Fan X, Li X, Kennedy D, Hao Y, Quan M, Chen X, Gao J, Zhang W, Zhang J, Lv L. Serum levels of BDNF, folate and homocysteine: in relation to hippocampal volume and psychopathology in drug naïve, first episode schizophrenia.  Schizophrenia Research, 2014; 159, 51-55. PMID: 25128453.
    24. Guo W, Hu M, Fan X, Liu F, W R, Chen J, Guo X, Xiao C, Quan M, Chen H, Zhai J, Zhao J.  Decreased gray matter volume in the left middle temporal gyrus as a candidate biomarker for schizophrenia: a study of drug naive, first-episode schizophrenia patients and unaffected siblings.  Schizophrenia Research, 2014; 159, 43-50. PMID: 25156295.
    25. Sheng J, Chiang C, Li C, Wang J, Harrington A, Yi Z, Liu D,Fan XPhenotypic characteristics in metabolically healthy but obese patients with schizophreniaPsychiatry Research, 2014; 220, 71-75. PMID: 25086765.
    26. Song X, Fan X, Zhang J, Zheng H, Li X, Pang L, Chen X, Zhang W, Ziedonis D, Lv L.  Prolactin serum levels correlate with inflammatory status in drug naïve first episode schizophrenia.  The World Journal of Biological Psychiatry, 2014; 15, 546-552. PMID: 24959913.
    27. Song X, Fan X, Li X, Zhang W, Gao J, Zhao J, Harrington A, Ziedonis D, Lv L.  Changes in pro-inflammatory cytokines and body weight during 6-month risperidone treatment in drug naïve, first episode schizophrenia.  Psychopharmacology (Berlin), 2014; 231, 319-325. PMID: 24337064.
    28. Guo X, Li J, Wang J, Fan X, Hu M, Shen Y, Chen H, Zhao J.  Hippocampal and orbital inferior frontal gray matter volume abnormalities and cognitive deficit in treatment-naïve, first-episode patients with schizophrenia.  Schizophrenia Research, 2014; 152, 339-343. PMID: 24439000.
    29. Ding M, Song X, Zhao J, Gao J, Li X, Yang G, Wang X, Harrington A, Ziedonis D, Fan X, Lv L. Activation of Th17 cells in drug naïve, first episode schizophrenia.  Prog Neuropsychopharmacol Biol Psychiatry, 2014; 51, 78-82. PMID: 24447943.
    30. Song X, Li X, Gao J, Ding M, Zhao J, Li Y,  Fan X, Lv L.  APOA-I: a possible novel biomarker for metabolic side effects in first episode schizophrenia.  PLoS One, 2014; 9, e93902. PMID: 24710015.
    31. Guo X, Li J, Wei Q, Fan X, Kennedy DN, Shen Y, Chen H, Zhao J.  Duration of untreated psychosis is associated with temporal and occipitotemporal gray matter volume decrease in treatment naïve schizophrenia.  PLoS One, 2013; 8, e83679. PMID: 24391807.
    32. Song X, Fan X, Zhang J, Zhang W, Li X, Gao J, Harrington A, Ziedonis D, Lv L.  Elevated levels of adiponectin and other cytokines in drug naïve, first episode schizophrenia patients with normal weight.  Schizophrenia Research, 2013; 150, 269-73. PMID: 23968860.
    33. Li J, Li X, Liu E, Song X, Copeland P, Freudenreich O, Goff DC, Henderson DC, Fan X.  No effect of adjunctive, repeated dose intranasal insulin treatment on body metabolism in patients with schizophrenia.  Schizophrenia Research, 2013; 146, 40-45. PMID: 23434504.
    34. Zhuo K, Lu Y, Yang Z, Fan X, Song Z, Liao L, Ji C, Zhu D, Yu S, Yan C, Chan RCK, Goff DC, Xu Y, Liu D.  Prospective memory performance in patients with drug-naïve, first-episode psychosis.  Schizophrenia Research, 2013; 143, 285-290. PMID: 23267733.
    35. Fan X, Song X.  Non-steroidal anti-inflammatory drugs may reduce schizophrenia symptom severity in the short term when added to antipsychotics.  Evidence based Mental Health, 2013; 16, 10. PMID: 23093694.
    36. Ou JJ, Xu Y, Chen HH, Fan X, Gao K, Wang J, Guo XF, Wu RR, Zhao JP.  Comparison of metabolic effects of ziprasidone versus olanzapine treatment in patients with first-episode schizophrenia.  Psychopharmacology (Berl), 2013; 225, 627-635. PMID: 22926006.
    37. Wang J,  Fan X, Liu D, Yi Z, Freudenreich O, Goff DC, Henderson DC.  Both physical activity and food intake are associated with metabolic risks in patients with schizophrenia.  Schizophrenia Research, 2012; 140, 260-261. PMID: 22682987.
    38. Yi Z, Fan X, Wang J, Liu D, Freudenreich O, Goff DC, Henderson DC.  Rosiglitazone and cognitive function in clozapine treated patients with schizophrenia: a pilot study.  Psychiatry Research, 2012; 200, 79-82. PMID: 22727707.
    39. Wang J, Liu E, Freudenreich O, Goff DC, Henderson DC, Fan X.  Phenotypic characteristics in metabolically obese but normal weight non-diabetic patients with schizophrenia.  Schizophrenia Research, 2010; 124, 49-53. PMID: 20947306.
    40. Liu D, Fan X, Wang Y, Yang Z, Zhuo K, Song Z, Wu Y, Li C, Wang J, Xu Y.  Deficient inhibition of return in chronic but not first-episode patients with schizophrenia.  Progress in Neuro-Psychopharmacology & Biological Psychiatry, 2010; 34, 961-967. PMID: 20460142.
    41. Fan X, Liu E, Freudenreich O, Park JH, Liu D, Wang J, Yi Z, Goff DC, Henderson DC.  Higher white blood cell counts are associated with an increased risk for metabolic syndrome and more severe psychopathology in non-diabetic patients with schizophrenia.  Schizophrenia Research, 2010; 118, 211-217. PMID: 20189773.